Related references
Note: Only part of the references are listed.Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
Hanny Al-Samkari et al.
Lancet Haematology (2022)
A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies
Hanny Al-Samkari et al.
HAEMATOLOGICA (2021)
The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies
Jaime L. Shaw et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled Trial
Sairah Ahmed et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular Carcinoma
Naim Alkhouri et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Eltrombopag treatment promotes platelet recovery and reduces platelet transfusion for patients with post-transplantation thrombocytopenia
Fei Gao et al.
ANNALS OF HEMATOLOGY (2020)
Safety and Efficacy of Eltrombopag and Romiplostim in Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis
Fanqiao Meng et al.
FRONTIERS IN ONCOLOGY (2020)
Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia
Gerald A. Soff et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Use of Thrombopoietin Receptor Agonists in Prolonged Thrombocytopenia after Hematopoietic Stem Cell Transplantation
Upendra Mahat et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors
Hanny Al-Samkari et al.
HAEMATOLOGICA (2018)
The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors
Hanny Al-Samkari et al.
HAEMATOLOGICA (2018)
A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia
Jennifer Miao et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial
Moshe Mittelman et al.
LANCET HAEMATOLOGY (2018)
Romiplostim for management of chemotherapy-induced thrombocytopenia
R. Parameswaran et al.
SUPPORTIVE CARE IN CANCER (2014)
Reactions Induced by Platelet Transfusions
Volker Kiefel
TRANSFUSION MEDICINE AND HEMOTHERAPY (2008)
Share Paper
